Management of Hypertensive Emergency with Spontaneous Intracranial Hemorrhage

Initial Assessment and Blood Pressure Management

The American Heart Association recommends that for patients with spontaneous intracranial hemorrhage and hypertensive emergency, blood pressure should be lowered to a target systolic BP of 140 mmHg, initiated within 2 hours of onset and reaching target within 1 hour 1, 2
Acute lowering of systolic BP to <130 mmHg is potentially harmful and should be avoided, as recommended by the American Stroke Association 1, 2
Careful titration of BP-lowering therapy is essential to ensure continuous, smooth, and sustained control of BP, avoiding peaks and large variability in systolic BP, according to the American Heart Association 2
For patients presenting with SBP >150 mmHg and <220 mmHg, acute lowering of SBP to 140 mmHg is safe and may improve functional outcomes, as stated by the American Stroke Association 2
For patients with very high BP (>220 mmHg), more cautious BP lowering may be required due to higher rates of neurological deterioration and renal adverse events, as recommended by the American Heart Association 3

The American College of Cardiology recommends that intravenous antihypertensive agents with rapid onset and short duration of action are preferred to facilitate easy titration and sustained BP control 2
Labetalol is a first-line agent, with a recommended dose of 5-20 mg IV bolus every 15 minutes or continuous infusion at 2 mg/min, as stated by the American Heart Association 4, 5
Avoid venous vasodilators (like nitroprusside) as they may have negative effects on hemostasis and intracranial pressure, according to the American Stroke Association 2
Labetalol may be preferred as it leaves cerebral blood flow relatively intact compared to nitroprusside and does not increase intracranial pressure, as recommended by the European Society of Cardiology 6

Continuous BP monitoring is essential for patients requiring IV antihypertensive medications, as stated by the American Heart Association 7
Monitor neurological status frequently using standard stroke scales such as NIHSS and GCS, according to the American Stroke Association 8
Avoid large fluctuations in BP as high SBP variability during the hyperacute and acute phases of ICH is associated with poor outcomes, as recommended by the American Heart Association 2
For patients with evidence or suspicion of elevated intracranial pressure (ICP), consider ICP monitoring and maintain cerebral perfusion pressure at 60-80 mmHg, as stated by the American Stroke Association 5

For patients on anticoagulants with spontaneous ICH, anticoagulation should be discontinued immediately and rapid reversal performed as soon as possible, according to the American Heart Association 3
For patients with large or severe ICH or those requiring surgical decompression, the safety and efficacy of intensive BP lowering are not well established, as stated by the American Stroke Association 2
Cardiopulmonary instability in association with increased ICP should be avoided to minimize deleterious effects in patients with limited autoregulatory capacity, as recommended by the American Heart Association 8

Lowering BP too aggressively (below 130 mmHg) can be harmful and is associated with worse outcomes, as stated by the American Heart Association 1, 2
Delayed initiation of BP control may increase risk of hematoma expansion, according to the American Stroke Association 2
Excessive BP variability during treatment is associated with poor outcomes, as recommended by the American Heart Association 2
Using medications that can increase ICP or reduce cerebral perfusion pressure should be avoided, as stated by the European Society of Cardiology 6, 8